S. Glastonbury, CT, United States of America

Mark Beauchemin

USPTO Granted Patents = 12 

 

Average Co-Inventor Count = 2.1

ph-index = 3

Forward Citations = 58(Granted Patents)


Company Filing History:


Years Active: 2014-2024

Loading Chart...
Loading Chart...
12 patents (USPTO):Explore Patents

Title: Mark Beauchemin: Innovator in Automated Reagent Verification and Sequencing Technologies

Introduction

Mark Beauchemin is a prominent inventor based in South Glastonbury, Connecticut, known for his significant contributions to the fields of automated reagent verification and sequencing technologies. With a total of 12 patents to his name, Beauchemin has made substantial advancements that enhance the efficiency and accuracy of laboratory processes.

Latest Patents

Among his latest innovations, Beauchemin developed a "System and method for automated reagent verification." This method involves a user-guided initiation of an instrument, which includes receiving a run plan through a user interface, indicating a consumable based on the run plan, detecting the presence of the consumable with a vision system, and confirming its presence via the user interface. Another notable patent is the "System and method for automated repeat sequencing." This method focuses on sequencing a target polynucleotide by detecting a series of nucleotide incorporations, moving substrates within an assembly, and ensuring the target nucleotide remains secured throughout the process.

Career Highlights

Beauchemin's career is marked by his role at Life Technologies Corporation, where he has been instrumental in developing cutting-edge technologies that streamline laboratory workflows. His expertise in automation and sequencing has positioned him as a key figure in the biotechnology industry.

Collaborations

Throughout his career, Beauchemin has collaborated with notable colleagues, including Todd Rearick and Melville Davey. These partnerships have fostered innovation and contributed to the successful development of his patented technologies.

Conclusion

Mark Beauchemin's work exemplifies the impact of innovation in the biotechnology sector. His patents not only advance scientific research but also improve the efficiency of laboratory operations. His contributions continue to shape the future of automated technologies in the field.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…